Spinal Cord Stimulator Device Market Size, Share, Global Trends, Major Key Players and Geographical Forecast Till 2030

The Spinal Cord Stimulator Device Market is expected to grow from US$ 2,779.91 million in 2022 to US$ 4,967.52 million by 2030; it is anticipated to record a CAGR of 7.5% from 2022 to 2030.

A spinal cord stimulation device is an implanted device that relieves pain by transmitting low-level electrical signals directly into the spinal cord. The stimulator is mostly used after nonsurgical pain treatments fail to provide sufficient relief. Additionally, the device can improve the overall quality of life and sleep. As it is typically prescribed along with other pain management treatments, it effectively suppresses the need for pain medicines. The spinal cord stimulator device market size is expanding with the rising number of spinal cord injuries (SCIs) and the availability of innovative treatments.

Get Exclusive Sample PDF @: https://www.premiummarketinsights.com/sample/TIP00044636?utm_source=OpenPr&utm_medium=10640

Analysis of the Top Market Players:

1. Boston Scientific Corp
2. Nevro Corp
3. Abbott Laboratories
4. Cirtec Medical Corp
5. Medtronic Plc
6. Biotronik SE & Co KG
7. Curonix LLC
8. Nalu Medical, Inc.
9. Synapse Biomedical Inc

In this report, the market has been segmented on the basis of:

Product Type

- Rechargeable
- Non-Rechargeable

Application

- Failed Back Syndrome
- Complex Regional Pain Syndrome
- Degenerative Disk Disease

End User

- Hospitals
- Ambulatory Surgery Centers (ASCs)

With advancements in medical knowledge and the introduction of effective medicines, various spinal cord stimulators are used in treatments. In addition to the multiple advantages of these devices-including portability, convenience, and effectiveness-the growing number of product approvals and developments is expected to propel the demand for spinal cord stimulator devices in the coming years.

Get full Report Description, TOC, Table of Figure, Chart, etc. @: https://www.premiummarketinsights.com/reports-tip/spinal-cord-stimulator-device-market

A few of the major developments and approvals in the spinal cord stimulator device market are listed below:
- In October 2023, Boston Scientific Corp won approval from the US FDA for the WaveWriter Alpha SCS systems for treating painful diabetic peripheral neuropathy (DPN), a disorder affecting the lower limbs of patients.

- In August 2023, Medtronic plc received CE (Conformity? Europenne) Mark for its Inceptiv. The device is a closed-loop rechargeable spinal cord stimulator (SCS). It is the first SCS device of the company to offer a closed-loop feature. Inceptive is equipped with technology that can sense each patient's unique biological signals, adjust stimulation as per the patient's moment, and offer harmonized therapy with the motions of daily life.

- In August 2022, Abbott Laboratories received approval from the US FDA for its Proclaim Plus SCS system to treat chronic pain. The BurstDR stimulation technology enables the device to deliver superior pain relief. It offers FlexBurst360 therapy that offers pain coverage across the trunk and limbs; the device can be programmed per the patient's evolving therapeutic needs.

- In September 2020, Boston Scientific announced the launch of the WaveWriter Alpha portfolio of spinal cord stimulator (SCS) Systems in the European market. The portfolio comprises four MRI, Bluetooth-enabled implantable pulse generators (IPGs), and additional personalization options based on patients' needs. These systems are available in rechargeable/non-rechargeable options, which cover multiple areas of pain.

Buy this research report at @: https://www.premiummarketinsights.com/buy/TIP00044636?utm_source=OpenPr&utm_medium=10640

Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.